2-(3-苯甲酰基苯基)乙酰氯 | 41652-38-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(3-苯甲酰基苯基)乙酰氯
• 英文名称: (3-benzoylphenyl)acetyl chloride
• 英文别名: m-benzoyl-phenyl-acetic acid chloride；2-(3-benzoylphenyl)acetyl chloride
• CAS: 41652-38-4
• 化学式: C₁₅H₁₁ClO₂
• 分子量: 258.704
• InChiKey: ZOVAGRBJMBDVDC-UHFFFAOYSA-N

物化性质

• 沸点：
  404.4±38.0 °C(Predicted)
• 密度：
  1.238±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  34.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(3-苯甲酰基苯基)乙酰氯 在 lithium aluminium tetrahydride 、 三乙胺 作用下， 以 乙醚 、 苯 为溶剂， 反应 51.5h， 生成 2,6-Dimethyl-1-{2-[3-(α-hydroxybenzyl)phenyl]ethyl}-piperidine
  参考文献：
  名称：

  酮洛芬的大块胺类似物：有效的抗炎药。

  摘要：

  用各种笨重的胺取代2-（3-苯甲酰基苯基）丙酸（酮洛芬）的羧基已产生了一系列高活性抗炎药，这些药物在21天的佐剂性关节炎试验中具有降低的肠溃疡性和更好的治疗率。大鼠比目前市售的非甾体类抗炎药。将这些2-（3-苯甲酰基苯基）丙基大分子胺还原为相应的醇或亚甲基类似物，将酮官能团转化为伯胺或肟，以及引入4-卤代取代基（Cl或F）在芳环末端。去除α-CH3基团大大降低了该系列的抗炎活性。

  DOI：

  10.1021/jm00378a027
• 作为产物：
  描述：

  3-苯甲酰苯基乙腈 在 氯化亚砜 、 硫酸 作用下， 以 溶剂黄146 、 苯 为溶剂， 反应 5.25h， 生成 2-(3-苯甲酰基苯基)乙酰氯
  参考文献：
  名称：

  酮洛芬的大块胺类似物：有效的抗炎药。

  摘要：

  用各种笨重的胺取代2-（3-苯甲酰基苯基）丙酸（酮洛芬）的羧基已产生了一系列高活性抗炎药，这些药物在21天的佐剂性关节炎试验中具有降低的肠溃疡性和更好的治疗率。大鼠比目前市售的非甾体类抗炎药。将这些2-（3-苯甲酰基苯基）丙基大分子胺还原为相应的醇或亚甲基类似物，将酮官能团转化为伯胺或肟，以及引入4-卤代取代基（Cl或F）在芳环末端。去除α-CH3基团大大降低了该系列的抗炎活性。

  DOI：

  10.1021/jm00378a027

文献信息

• 4-[[3-[.alpha.-Aminobenzyl]phenyl]methyl]morpholine and
  申请人：Sterling Drug Inc.

  公开号：US04308382A1

  公开（公告）日：1981-12-29

  N-2, 3- and 4-[R.sub.1 -(phenyl)-C(=X)]-phenyl-lower-alkyl}amines, useful as anti-inflammatory agents, are prepared either by reduction of 2-, 3- or 4-[R.sub.1 -(phenyl)-CO]-phenyl-lower-alkanoylamines, which are also useful as anti-inflammatory agents; by benzoylating a phenyl-lower-alkylamine; by reaction of a 2-, 3- or 4-lithiophenyl-lower-alkylamine with a R.sub.1 -(phenyl)-carboxaldehyde, a R.sub.1 -(phenyl)-lower-alkyl ketone or a R.sub.1 -(phenyl)-carbonitrile; by reaction of a 2-, 3- or 4-[R.sub.1 -(phenyl)-CO]-phenyl-lower-alkyl tosylate with an appropriate amine; or by transformations involving manipulations of a carbonyl or carbinol group.

  N-2, 3-和4-[R1-(苯基)-C(=X)]-苯基-低碳烷基}胺，作为抗炎药很有用，可以通过还原2-, 3-或4-[R1-(苯基)-CO]-苯基-低碳烷酰胺来制备，这些低碳烷酰胺作为抗炎药也很有效；通过苯甲酰化苯基-低碳烷基胺；通过与R1-(苯基)-甲酰甲醛、R1-(苯基)-低碳烷基酮或R1-(苯基)-腈的2-, 3-或4-锂苯基-低碳烷基胺反应；通过与适当胺的2-, 3-或4-[R1-(苯基)-CO]-苯基-低碳烷基甲磺酸酯反应；或者通过涉及羰基或甲醇基团操纵的转化来制备。
• Intermediates for preparing anti-inflammatory phenyl-lower-alkylamines
  申请人：Sterling Drug Inc.

  公开号：US04216326A1

  公开（公告）日：1980-08-05

  N-3- and 4-[R.sub.1 -(phenyl)-C(.dbd.X)]-phenyl-lower-alkyl}amines, useful as anti-inflammatory agents, are prepared either by reduction of 3- or 4-[R.sub.1 -(phenyl)-CO]-phenyl-lower-alkanoylamines, which are also useful as anti-inflammatory agents; by benzoylating a phenyl-lower-alkylamine; by reaction of a 3- or 4-lithiophenyl-lower-alkylamine with a R.sub.1 -(phenyl)-carboxaldehyde, a R.sub.1 -(phenyl)-lower-alkyl ketone or a R.sub.1 -(phenyl)-carbonitrile or by transformations involving manipulations of a carbonyl or carbinol group.

  N-3-和4-[R1-(苯基)-C(=X)]-苯基-低碳烷基}胺，作为抗炎药有效，可以通过还原3-或4-[R1-(苯基)-CO]-苯基-低碳烷酰胺制备，后者也作为抗炎药有效；通过苯甲酰化苯基-低碳烷基胺；通过与R1-(苯基)-甲醛、R1-(苯基)-低碳烷基酮或R1-(苯基)-腈的3-或4-锂苯基-低碳烷基胺反应，或者通过涉及羰基或甲醇基团操纵的转化来制备。
• Anti-inflammatory phenyl-lower-alkylamines
  申请人：Sterling Drug Inc.

  公开号：US04069256A1

  公开（公告）日：1978-01-17

  N-3-[R.sub.1 -(phenyl)-C(=X)]-phenyl-lower-alkyl}amines having anti-inflammatory utility are prepared either by reduction of a 3-[R.sub.1 -(phenyl)-CO]-phenyl-lower-alkanoylamine; by benzoylating a phenyl-lower-alkylamine; by reaction of a 3-lithiophenyl-lower-alkylamine with a R.sub.1 -(phenyl)-carboxaldehyde, a R.sub.1 -(phenyl)lower-alkyl ketone or a R.sub.1 -(phenyl)-carbonitrile or by transformations involving manipulations of a carbonyl or carbinol group.

  具有抗炎活性的N-3-[R₁-(苯基)-C(=X)]-苯基-低碳烷基}胺可以通过以下方式制备：还原3-[R₁-(苯基)-CO]-苯基-低碳烷酰胺；通过苯甲酰化苯基-低碳烷基胺；通过3-锂代苯基-低碳烷基胺与R₁-(苯基)-甲酰甲醛、R₁-(苯基)低碳烷基酮或R₁-(苯基)-碳氰化物的反应；或者通过涉及羰基或甲醇基团操作的转换过程。
• 4-(M-benzoylphenyl)butyric acid derivatives
  申请人：Roussel-UCLAF

  公开号：US03931302A1

  公开（公告）日：1976-01-06

  Novel butyric acid derivatives of the formula ##SPC1## Wherein X, X.sub.1, X.sub.2 and X.sub.3 are individually selected from the group consisting of hydrogen, halogen, lower alkyl of 1 to 5 carbon atoms, lower alkoxy of 1 to 5 carbon atoms, lower alkylthio of 1 to 5 carbon atoms, trifluoromethoxy, trifluoromethylthio, trifluoromethyl, OH and dilower alkylamino of 1 to 5 carbon atoms for each alkyl, R is selected from the group consisting of hydrogen, lower alkyl of 1 to 5 carbon atoms, o-carboxyphenyl, 2,3-dihydroxypropyl and -CH.sub.2 -CH - CH.sub.2 ##EQU1## wherein P and Q are individually lower alkyl of 1 to 5 carbon atoms, Z and X.sub.4 are individually selected from the group consisting of hydrogen and lower alkyl of 1 to 5 carbon atoms and Y is selected from the group consisting of hydrogen and --OH and the dotted line indicates the optional presence of a double bond when Y is hydrogen and when R is hydrogen or o-carboxyphenyl, the salts thereof with a non-toxic pharmaceutically acceptable mineral or organic base, which compounds have anti-inflammatory and analgesic activity and are substantially devoid of ulcerigenic activity and their preparation and novel intermediates formed therein.

  新型丁酸衍生物，其通式如##SPC1##所示，其中X、X₁、X₂和X₃各自独立地选自氢、卤素、含有1至5个碳原子的低级烷基、含有1至5个碳原子的低级烷氧基、含有1至5个碳原子的低级烷基硫基、三氟甲氧基、三氟甲基硫基、三氟甲基、羟基以及每个烷基含有1至5个碳原子的二低级烷基氨基；R选自氢、含有1至5个碳原子的低级烷基、邻羧基苯基、2,3-二羟基丙基以及-CH₂-CH-CH₂##EQU1##其中P和Q各自独立地为含有1至5个碳原子的低级烷基，Z和X₄各自独立地选自氢和含有1至5个碳原子的低级烷基，Y选自氢和--OH，虚线表示当Y为氢且R为氢或邻羧基苯基时可能存在的双键；与无毒的药用可接受的矿物或有机碱形成的盐，这些化合物具有抗炎和镇痛活性，且基本上无致溃疡活性，以及它们的制备方法和在其中形成的新型中间体。
• Butyric acid derivatives for treating pain and inflammation
  申请人：Roussel-UCLAF

  公开号：US03995056A1

  公开（公告）日：1976-11-30

  Novel butyric acid derivatives of the formula ##SPC1## Wherein X, X.sub.1, X.sub.2 and X.sub.3 are individually selected from the group consisting of hydrogen, halogen, lower alkyl of 1 to 5 carbon atoms, lower alkoxy of 1 to 5 carbon atoms, lower alkylthio of 1 to 5 carbon atoms, trifluoromethoxy, trifluoromethylthio, trifluoromethyl, OH and dilower alkylamino of 1 to 5 carbon atoms for each alkyl, R is selected from the group consisting of hydrogen, lower alkyl of 1 to 5 carbon atoms, o-carboxyphenyl, 2,3-dihydroxypropyl and ##EQU1## wherein P and Q are individually lower alkyl of 1 to 5 carbon atoms, Z and X.sub.4 are individually selected from the group consisting of hydrogen and lower alkyl of 1 to 5 carbon atoms and Y is selected from the group consisting of hydrogen and --CH and the dotted line indicates the optional presence of a double bond when Y is hydrogen and when R is hydrogen or o-carboxyphenyl, the salts thereof with a non-toxic pharmaceutically acceptable mineral or orgaic base, which compounds have anti-inflammatory and analgesic activity and are substantially devoid of ulcerigenic activity and their preparation and novel intermediates formed therein.

  化合物的结构式为：##SPC1## 其中X，X.sub.1，X.sub.2和X.sub.3分别从氢，卤素，1至5个碳原子的低级烷基，1至5个碳原子的低级烷氧基，1至5个碳原子的低级烷硫基，三氟甲氧基，三氟甲基硫基，三氟甲基，OH和每个烷基的1至5个碳原子的二级烷胺中选择，而R从氢，1至5个碳原子的低级烷基，o-羧基苯基，2,3-二羟基丙基和##EQU1##中选择，其中P和Q分别是1至5个碳原子的低级烷基，Z和X.sub.4分别从氢和1至5个碳原子的低级烷基中选择，而Y从氢和--CH中选择，虚线表示当Y为氢时，当R为氢或o-羧基苯基时，存在一个可选的双键。这些化合物与无毒的药用矿物质或有机碱的盐具有抗炎和镇痛活性，并且基本上不具有溃疡原性活性，其制备和形成的新中间体。